Skip to main content

LCE 150 (Carbidopa, Entacapone and Levodopa 37.5 mg / 200 mg / 150 mg)

Pill with imprint LCE 150 is Brown, Elliptical/Oval and has been identified as Carbidopa, Entacapone and Levodopa 37.5 mg / 200 mg / 150 mg. It is supplied by Sandoz Inc.

Carbidopa/entacapone/levodopa is used in the treatment of parkinson's disease and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Carbidopa/entacapone/levodopa 37.5 mg / 200 mg / 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for LCE 150

Carbidopa, Entacapone and Levodopa

LCE 150
37.5 mg / 200 mg / 150 mg
Prescription only
Drug Class
Dopaminergic antiparkinsonism agents
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Sandoz Inc
Inactive Ingredients
corn starch, croscarmellose sodium, glycerin, hypromelloses, magnesium stearate, mannitol, polysorbate 80, povidone, sucrose, ferric oxide red, titanium dioxide, ferric oxide yellow

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00781-5654 Sandoz Inc.
00078-0409 (Discontinued) Novartis Pharmaceuticals Corporation

Get help with Imprint Code FAQs.

Related images for "LCE 150"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.